echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JPD: Virtual reality is here!

    JPD: Virtual reality is here!

    • Last Update: 2022-02-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Parkinson's disease (PD) is a common neurological disorder characterized by motor dysfunction and early cognitive dysfunction in some patients
    .


    Major cognitive impairments affect executive function, visuospatial perception, abstract thinking, memory, and verbal fluency, which can severely reduce quality of life


    Quality of Life

    The pathophysiology of cognitive impairment in PD remains unclear
    .


    Changes in the levels of neurotransmitters such as acetylcholine and dopamine may be one mechanism


    VR is a technological tool that involves the use of a three-dimensional computer-generated environment to detect the user's actions and location while providing a sense of presence in the environment
    .


    Interaction with virtual objects enables users to experience multisensory feedback (such as visual, auditory, and kinesthetic) similar to feedback received in real life



    Emerging evidence suggests that the combination of transcranial magnetic stimulation and exercise training has a potential therapeutic role for exercise rehabilitation, and the study reports that the priming effect of transcranial magnetic stimulation in increasing cortical excitability can enhance the effect of subsequent exercise training, thereby increasing the Exercise recovery in stroke and multiple sclerosis patients
    .


    Considering that both VR and rTMS can improve cognitive function by addressing the neuronal and behavioral aspects of cognitive effects, an integrated approach may lead to more sensitive rehabilitation of cognitive symptoms in PD patients
    .


    Positive effects of combined NIBS and VR therapy on motor and cognitive function


    Taking this, Tsai-Chin Chenga et al.


    of Yangming University in Taiwan, China, hypothesized that the integration of VR training and rTMS could enhance the cognitive improvement of rTMS in patients with PD and MCI


    Hypothesized that the integration of VR training with rTMS could enhance the cognitive improvement of rTMS in PD and MCI patients

    They randomized 40 PD and MCI patients into three groups, rTMS-VR group (n = 13), rTMS group (n = 11), and sham rTMS group (n = 16)
    .


    rTMS is 10 consecutive intermittent theta-pulse stimulation (iTBS) on the left dorsolateral prefrontal cortex


    In the rTMS-VR group, VR training was performed immediately after each rTMS treatment
    .


    Cognitive function was measured using the Reproducible Assessment of Neuropsychological Status (RBANS) and the Montreal Cognitive Assessment (MoCA) at baseline, immediately after intervention, and at 3-month follow-up


    They found that compared with the rTMS group, the rTMS-VR group showed significantly more improvements in post-intervention RBANS total and delayed memory scores and MoCA visuospatial/executive function scores (P = 0.


    000∼0.


    The significance of this study lies in the discovery that the comprehensive rTMS-VR regimen achieved significant effects on global cognitive function, enhancing working memory and visuospatial executive function more effectively than the rTMS regimen alone
    .
    The combination of VR and rTMS can be an effective solution to improve cognitive function in PD patients
    .

    Comprehensive rTMS-VR scheme achieves clear results in global cognitive function


    Original source:
    Cheng TC, Huang SF, Wu SY, Lin FG, Lin WS, Tsai PY.
    Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson's Disease with Cognitive 6 Impairment: A Proof-of-Concept Study.

    Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson's Disease with Cognitive 6 Impairment: A Proof-of-Concept Study.
    Leave a Comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.